Elle Kielar Grevstad, PhD, explains how a 2-MDM panel detected endometrial cancer in self-collected vaginal fluid with 96% sensitivity and 82% specificity, according to a marker reduction study published in Gynecologic Oncology.
Elle Kielar Grevstad, PhD
Advertisement
Elle Kielar Grevstad, PhD, Director, Product Strategy, Abbott Cancer Diagnostics, University of Wisconsin–Madison, and co-author of the study.
Articles by Elle Kielar Grevstad, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA: Levonorgestrel/ethinyl estradiol birth control patch sees update to labeled strength
2
Spotlighting menopause and mental health with Jessica Gaulton, MD, MPH
3
Q+A: Fiona Baker, PhD, on sleep disturbances in menopause and the role of vasomotor symptoms
4
Interpreting elinzanetant data and benefits on sleep in postmenopausal women
5